Healthcare is absolutely a business, and in the United States, it is one of the largest. The country spent $5.3 trillion on healthcare in 2024, accounting for 18% of GDP, or about $15,474 per person. That figure is projected to reach 20.3% of GDP by 2033. Whether people are comfortable with that reality is a separate question from whether it’s true.
But healthcare is also not purely a business. It exists in a tension between profit motives and a public mission that no other industry quite shares. Understanding how those forces interact helps explain why your medical bill looks the way it does.
How Healthcare Makes Money
Healthcare operates through a mix of for-profit and nonprofit structures, and the distinction matters less than most people assume. For-profit hospitals and insurers work like any corporation: they answer to shareholders and aim to generate returns. Nonprofit hospitals, which make up the majority in the U.S., are exempt from federal and some state and local taxes. In exchange, the IRS requires them to meet a “community benefit standard,” which includes factors like operating an emergency room open to everyone regardless of ability to pay, maintaining a board drawn from the community, accepting Medicare and Medicaid patients, and providing financial assistance to people who can’t afford care.
The word “nonprofit” can be misleading. These organizations still generate surplus revenue. They’re simply required to reinvest it into facilities, equipment, patient care, medical training, or research rather than distributing it to shareholders. That reinvestment obligation doesn’t prevent them from operating with the same competitive intensity as their for-profit counterparts.
CEO compensation at nonprofit hospitals illustrates the point. Between 2005 and 2015, average CEO pay at 22 major nonprofit medical centers rose 92%, from $1.6 million to $3.1 million. A broader study found that across a more diverse sample of nonprofit hospital CEOs, mean compensation grew 34% (adjusted for inflation) between 2012 and 2019, reaching about $1.3 million. For comparison, nonprofit leaders in other sectors averaged between $120,000 and $180,000 during the same period. These are business-level salaries by any measure.
The Pharmaceutical Profit Engine
Drug companies sit at the most openly commercial end of the healthcare spectrum. A Harvard Kennedy School analysis found that from 2000 to 2018, pharmaceutical companies in the S&P 500 had a median annual net income margin of 13.8%, compared with 7.7% for non-healthcare companies in the same index. That gap was statistically significant even after controlling for other variables, though margins showed some decline over time.
Pharmaceutical firms argue that high margins fund the research pipeline for future drugs, many of which fail. Critics counter that these companies routinely spend more on marketing and stock buybacks than on research. Both things can be true simultaneously, and neither changes the core fact: drug development is structured as a profit-seeking enterprise with patent protections that grant temporary monopolies on pricing.
What Ownership Structure Means for Patients
The business model behind a hospital can affect the care you receive. A large meta-analysis published in the Canadian Medical Association Journal compared mortality rates between for-profit and nonprofit private hospitals. After adjusting for patient characteristics, for-profit hospitals were associated with a 2% higher relative risk of death among adult patients. One perinatal study found a nearly 10% higher relative risk of death in for-profit facilities.
The difference appears to be partly explained by staffing. Two studies within the meta-analysis found that when researchers adjusted for staffing levels, such as the proportion of registered nurses and board-certified specialists, the mortality gap shrank. In one case the relative risk dropped from 1.06 to 1.04, and in another from 1.03 to 1.01. This suggests that for-profit hospitals may achieve their margins in part by running leaner staffing, which can affect outcomes at the margins.
A 2% difference in relative risk sounds small, but applied across millions of hospitalizations each year, it translates to a meaningful number of lives.
Private Equity’s Growing Role
One of the clearest signs that healthcare functions as a business is the flow of investment capital into it. Private equity firms, which buy companies with the explicit goal of increasing their value and selling them for profit, owned or invested in about 6.5% of physician practices nationally as of 2024, according to the U.S. Government Accountability Office. That share is small but growing, and it’s concentrated in certain specialties and geographic markets where returns are highest: dermatology, gastroenterology, ophthalmology, and emergency medicine among them.
The private equity playbook typically involves acquiring multiple practices, consolidating their purchasing and billing, reducing overhead, and then selling the combined entity at a premium. Whether this improves or degrades care depends on how aggressively the new owners cut costs and how quickly they aim to exit.
The Administrative Cost Problem
One reason U.S. healthcare costs so much is that a huge portion of spending goes not to doctors, nurses, or medical equipment but to paperwork. Administrative spending accounts for an estimated 15 to 30 percent of total medical spending in the United States. On a per-person basis, the U.S. spends $1,055 per capita on administrative costs, far more than any comparable country. Germany, the next highest spender among a group of twelve OECD nations, spends $306 per capita.
This overhead exists because the U.S. healthcare system involves thousands of private insurers, each with its own billing codes, prior authorization requirements, and claims processes. Every hospital and physician practice needs staff dedicated to navigating these systems. In countries with a single payer or a small number of standardized insurers, that bureaucratic layer is dramatically thinner. The administrative complexity is, in a real sense, the cost of running healthcare as a fragmented marketplace rather than a coordinated system.
How Other Countries Structure It Differently
The degree to which healthcare operates as a business varies dramatically across the developed world. About half of OECD countries use government financing as the primary mechanism for covering healthcare costs. This is the model in the United Kingdom, the Nordic countries, and most other Anglo-Saxon nations, where the government collects taxes and funds care directly. Hospitals in these systems may still be run with efficiency targets and budget constraints, but profit generation is not the point.
A second group of countries, including Germany, France, the Netherlands, and Switzerland, relies on compulsory health insurance that is privately produced but heavily regulated. In Germany, for instance, most people are enrolled in nonprofit “sickness funds” that compete for members but operate within strict government rules on coverage and pricing. The insurance market exists, but it functions more like a regulated utility than a free market.
The United States blends elements of both models, with government programs like Medicare and Medicaid covering about 40% of the population, employer-sponsored private insurance covering most working-age adults, and a significant uninsured population filling the gaps. This hybrid structure creates more opportunities for profit at every layer, from insurance to hospital ownership to drug pricing, than any other wealthy nation’s system.
Business and Mission at the Same Time
The honest answer to whether healthcare is a business is that it functions as one while also carrying obligations that no ordinary business has. Hospitals cannot turn away patients in emergencies. Insurers must cover certain essential benefits. Drug companies operate under FDA oversight that no consumer goods manufacturer faces. These constraints exist precisely because society recognizes that healthcare is different from selling cars or software.
Yet within those constraints, every major player in the system, from insurers to hospital networks to pharmaceutical companies to device manufacturers, operates with revenue targets, growth strategies, and executive compensation tied to financial performance. The $5.3 trillion flowing through U.S. healthcare annually creates powerful incentives that shape everything from which treatments get developed to how long you wait on hold with your insurance company. Healthcare is a business in the same way that education and energy are businesses: the product is essential, the market is imperfect, and the tension between profit and public good is never fully resolved.